Search research articles
Contact Us
Filters
Showing results (21-30 of 414) with videos related to
Page
of 42
Sort By:
Pharmacoepidemiology and Drug Safety
|
October 12, 2013
Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin
Kevin Fain, G Caleb Alexander
Archives of Internal Medicine
|
January 30, 2008
The nuances of self-disclosure
G Caleb Alexander, John Lantos
Pharmacoepidemiology and Drug Safety
|
April 8, 2014
Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin
Kevin Fain, G Caleb Alexander
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2002
Variation in access to kidney transplantation across dialysis facilities: using process of care measures for quality improvement
G Caleb Alexander, Ashwini R Sehgal,
Developmental Medicine and Child Neurology
|
June 28, 2021
Opioid use disorder during pregnancy: long-term developmental outcomes
Rachel H Alinsky, G Caleb Alexander
Health Affairs (Project Hope)
|
October 1, 2003
Ready and willing? Physicians' sense of preparedness for bioterrorism
G Caleb Alexander, Matthew K Wynia
JAMA
|
April 10, 2020
Ensuring Access to Medications in the US During the COVID-19 Pandemic
G Caleb Alexander, Dima M Qato
Pharmacotherapy
|
July 5, 2012
Is treatment heterogeneity an Achilles' heel for comparative effectiveness research?
G Caleb Alexander, Bruce L Lambert
The Virtual Mentor : VM
|
December 21, 2012
How good is good enough?
G Caleb Alexander, Robert C Bowman
Journal of General Internal Medicine
|
December 20, 2008
Turning and churning: loss of health insurance among adults in Medicaid
Milda R Saunders, G Caleb Alexander
Page
of 42
Search research articles
Search
Showing results (21-30 of 414) with videos related to
Sort By:
Page
of 42
Pharmacoepidemiology and Drug Safety
|
October 12, 2013
Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin
Kevin Fain, G Caleb Alexander
Archives of Internal Medicine
|
January 30, 2008
The nuances of self-disclosure
G Caleb Alexander, John Lantos
Pharmacoepidemiology and Drug Safety
|
April 8, 2014
Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin
Kevin Fain, G Caleb Alexander
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2002
Variation in access to kidney transplantation across dialysis facilities: using process of care measures for quality improvement
G Caleb Alexander, Ashwini R Sehgal,
Developmental Medicine and Child Neurology
|
June 28, 2021
Opioid use disorder during pregnancy: long-term developmental outcomes
Rachel H Alinsky, G Caleb Alexander
Health Affairs (Project Hope)
|
October 1, 2003
Ready and willing? Physicians' sense of preparedness for bioterrorism
G Caleb Alexander, Matthew K Wynia
JAMA
|
April 10, 2020
Ensuring Access to Medications in the US During the COVID-19 Pandemic
G Caleb Alexander, Dima M Qato
Pharmacotherapy
|
July 5, 2012
Is treatment heterogeneity an Achilles' heel for comparative effectiveness research?
G Caleb Alexander, Bruce L Lambert
The Virtual Mentor : VM
|
December 21, 2012
How good is good enough?
G Caleb Alexander, Robert C Bowman
Journal of General Internal Medicine
|
December 20, 2008
Turning and churning: loss of health insurance among adults in Medicaid
Milda R Saunders, G Caleb Alexander
Page
of 42